Marker Therapeutics MRKR
NASDAQ MRKR
$1.07 -0.06 (-5.31%)
At close: Oct 22, 2026 · 4:00 PM EDT

Marker Therapeutics (MRKR) Price to Earnings (2016)

Updated

Marker Therapeutics' (MRKR) Price to Earnings came in at 1.30 for Q2 2016.

Analysis

Marker Therapeutics (MRKR) Price to Earnings (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.75 Bn 1,113.34 Bn 19.71 Bn
2 Johnson & Johnson 635.80 Bn 555.66 Bn 17.30 Bn
3 AbbVie 502.77 Bn 475.88 Bn 12.70 Bn
4 Merck 356.48 Bn 310.86 Bn 12.21 Bn
5 Novartis Ag 301.04 Bn 265.03 Bn 11.24 Bn
6 Astrazeneca 264.46 Bn 238.15 Bn 12.86 Bn
7 Amgen 238.99 Bn 194.39 Bn 7.24 Bn
8 Gilead Sciences 194.94 Bn 169.14 Bn 6.22 Bn
9 Pfizer 170.77 Bn 117.42 Bn 10.94 Bn
10 Marker Therapeutics 20.09 Mn -39.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 1.30
API Access

Marker Therapeutics Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=MRKR&period=max&api_key=YOUR_API_KEY